C
Veracyte, Inc.
VCYT
$30.43
-$0.53-1.71%
C
Hold
3/3/2025Upgraded
Veracyte, Inc. (VCYT) was upgraded to C- from D- on 3/3/2025 due to a substantial increase in the efficiency index, growth index and total return index. Total capital increased 2.58% from $1.2B to $1.23B, and total revenue increased 2.39% from $115.86M to $118.63M.
Veracyte, Inc. (VCYT) was upgraded to C- from D- on 3/3/2025 due to a substantial increase in the efficiency index, growth index and total return index. Total capital increased 2.58% from $1.2B to $1.23B, and total revenue increased 2.39% from $115.86M to $118.63M.
D
Sell
12/12/2023Upgraded
Veracyte, Inc. (VCYT) was upgraded to D- from E+ on 12/12/2023 due to an increase in the total return index and volatility index.
Veracyte, Inc. (VCYT) was upgraded to D- from E+ on 12/12/2023 due to an increase in the total return index and volatility index.
E
Sell
11/24/2023Downgrade
Veracyte, Inc. (VCYT) was downgraded to E+ from D- on 11/24/2023 due to a decline in the valuation index.
Veracyte, Inc. (VCYT) was downgraded to E+ from D- on 11/24/2023 due to a decline in the valuation index.
D
Sell
11/9/2023Upgraded
Veracyte, Inc. (VCYT) was upgraded to D- from E+ on 11/9/2023 due to an increase in the valuation index.
Veracyte, Inc. (VCYT) was upgraded to D- from E+ on 11/9/2023 due to an increase in the valuation index.
E
Sell
9/18/2023Downgrade
Veracyte, Inc. (VCYT) was downgraded to E+ from D- on 9/18/2023 due to a decline in the total return index and volatility index.
Veracyte, Inc. (VCYT) was downgraded to E+ from D- on 9/18/2023 due to a decline in the total return index and volatility index.
D
Sell
9/1/2023Upgraded
Veracyte, Inc. (VCYT) was upgraded to D- from E+ on 9/1/2023 due to a major increase in the growth index, total return index and volatility index. Operating cash flow increased 867.54% from -$2.17M to $16.67M, EBIT increased 15.9% from -$9.57M to -$8.05M, and total revenue increased 9.58% from $82.42M to $90.32M.
Veracyte, Inc. (VCYT) was upgraded to D- from E+ on 9/1/2023 due to a major increase in the growth index, total return index and volatility index. Operating cash flow increased 867.54% from -$2.17M to $16.67M, EBIT increased 15.9% from -$9.57M to -$8.05M, and total revenue increased 9.58% from $82.42M to $90.32M.
E
Sell
5/12/2023Downgrade
Veracyte, Inc. (VCYT) was downgraded to E+ from D- on 5/12/2023 due to a significant decline in the growth index and volatility index. Operating cash flow declined 122.29% from $9.74M to -$2.17M, earnings per share declined from -$0.0535 to -$0.1121, and EBIT declined 83.95% from -$5.2M to -$9.57M.
Veracyte, Inc. (VCYT) was downgraded to E+ from D- on 5/12/2023 due to a significant decline in the growth index and volatility index. Operating cash flow declined 122.29% from $9.74M to -$2.17M, earnings per share declined from -$0.0535 to -$0.1121, and EBIT declined 83.95% from -$5.2M to -$9.57M.
D
Sell
3/14/2023Downgrade
Veracyte, Inc. (VCYT) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
Veracyte, Inc. (VCYT) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
Veracyte, Inc. (VCYT) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index and total return index.
Veracyte, Inc. (VCYT) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index and total return index.
D
Sell
2/8/2023Downgrade
Veracyte, Inc. (VCYT) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index, solvency index and valuation index.
Veracyte, Inc. (VCYT) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index, solvency index and valuation index.
D
Sell
5/16/2022Upgraded
Veracyte, Inc. (VCYT) was upgraded to D from E+ on 05/16/2022.
Veracyte, Inc. (VCYT) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
Veracyte, Inc. (VCYT) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
Veracyte, Inc. (VCYT) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/6/2022Upgraded
Veracyte, Inc. (VCYT) was upgraded to D from D- on 5/6/2022 due to an increase in the growth index. EBIT increased 56.06% from -$34.71M to -$15.25M, and total revenue increased 0.66% from $67.34M to $67.78M.
Veracyte, Inc. (VCYT) was upgraded to D from D- on 5/6/2022 due to an increase in the growth index. EBIT increased 56.06% from -$34.71M to -$15.25M, and total revenue increased 0.66% from $67.34M to $67.78M.
D
Sell
4/20/2022Downgrade
Veracyte, Inc. (VCYT) was downgraded to D- from D on 4/20/2022 due to a decline in the volatility index and total return index.
Veracyte, Inc. (VCYT) was downgraded to D- from D on 4/20/2022 due to a decline in the volatility index and total return index.
D
Sell
4/18/2022Downgrade
Veracyte, Inc. (VCYT) was downgraded to D from D+ on 4/18/2022 due to a decline in the total return index and volatility index.
Veracyte, Inc. (VCYT) was downgraded to D from D+ on 4/18/2022 due to a decline in the total return index and volatility index.
D
Sell
3/2/2022Upgraded
Veracyte, Inc. (VCYT) was upgraded to D+ from D on 3/2/2022 due to an increase in the growth index, valuation index and total return index. Operating cash flow increased 706.32% from -$1.39M to $8.45M, earnings per share increased from -$0.2026 to -$0.1481, and total revenue increased 11.54% from $60.37M to $67.34M.
Veracyte, Inc. (VCYT) was upgraded to D+ from D on 3/2/2022 due to an increase in the growth index, valuation index and total return index. Operating cash flow increased 706.32% from -$1.39M to $8.45M, earnings per share increased from -$0.2026 to -$0.1481, and total revenue increased 11.54% from $60.37M to $67.34M.
D
Sell
1/3/2022Downgrade
Veracyte, Inc. (VCYT) was downgraded to D from D+ on 1/3/2022 due to a significant decline in the total return index and growth index. Operating cash flow declined 173.82% from $1.89M to -$1.39M, EBIT declined 101.78% from -$7.47M to -$15.08M, and earnings per share declined from -$0.1343 to -$0.2026.
Veracyte, Inc. (VCYT) was downgraded to D from D+ on 1/3/2022 due to a significant decline in the total return index and growth index. Operating cash flow declined 173.82% from $1.89M to -$1.39M, EBIT declined 101.78% from -$7.47M to -$15.08M, and earnings per share declined from -$0.1343 to -$0.2026.
D
Sell
11/9/2021Upgraded
Veracyte, Inc. (VCYT) was upgraded to D+ from D- on 11/09/2021.
Veracyte, Inc. (VCYT) was upgraded to D+ from D- on 11/09/2021.
D
Sell
11/8/2021Downgrade
Veracyte, Inc. (VCYT) was downgraded to D- from D+ on 11/8/2021 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 10.76 to 9.95.
Veracyte, Inc. (VCYT) was downgraded to D- from D+ on 11/8/2021 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 10.76 to 9.95.
D
Sell
2/8/2021Upgraded
Veracyte, Inc. (VCYT) was upgraded to D+ from D on 2/8/2021 due to a significant increase in the total return index and volatility index.
Veracyte, Inc. (VCYT) was upgraded to D+ from D on 2/8/2021 due to a significant increase in the total return index and volatility index.
D
Sell
5/1/2020Downgrade
Veracyte, Inc. (VCYT) was downgraded to D from D+ on 5/1/2020 due to a large decline in the efficiency index, valuation index and volatility index.
Veracyte, Inc. (VCYT) was downgraded to D from D+ on 5/1/2020 due to a large decline in the efficiency index, valuation index and volatility index.
D
Sell
3/27/2020Downgrade
Veracyte, Inc. (VCYT) was downgraded to D+ from C- on 3/27/2020 due to a noticeable decline in the total return index and volatility index.
Veracyte, Inc. (VCYT) was downgraded to D+ from C- on 3/27/2020 due to a noticeable decline in the total return index and volatility index.
C
Hold
3/12/2020Upgraded
Veracyte, Inc. (VCYT) was upgraded to C- from D+ on 3/12/2020 due to an increase in the total return index and growth index.
Veracyte, Inc. (VCYT) was upgraded to C- from D+ on 3/12/2020 due to an increase in the total return index and growth index.
D
Sell
2/26/2020Downgrade
Veracyte, Inc. (VCYT) was downgraded to D+ from C- on 2/26/2020 due to a large decline in the growth index and efficiency index. Net income declined 921.64% from -$730 to -$7.46M, earnings per share declined from -$0.015 to -$0.1518, and EBIT declined 364.95% from -$1.76M to -$8.2M.
Veracyte, Inc. (VCYT) was downgraded to D+ from C- on 2/26/2020 due to a large decline in the growth index and efficiency index. Net income declined 921.64% from -$730 to -$7.46M, earnings per share declined from -$0.015 to -$0.1518, and EBIT declined 364.95% from -$1.76M to -$8.2M.
C
Hold
10/23/2019Upgraded
Veracyte, Inc. (VCYT) was upgraded to C- from D+ on 10/23/2019 due to a large increase in the growth index and efficiency index. Net income increased 70.73% from -$2.49M to -$730, earnings per share increased from -$0.0547 to -$0.02, and EBIT increased 43.13% from -$3.1M to -$1.76M.
Veracyte, Inc. (VCYT) was upgraded to C- from D+ on 10/23/2019 due to a large increase in the growth index and efficiency index. Net income increased 70.73% from -$2.49M to -$730, earnings per share increased from -$0.0547 to -$0.02, and EBIT increased 43.13% from -$3.1M to -$1.76M.
D
Sell
10/9/2019Downgrade
Veracyte, Inc. (VCYT) was downgraded to D+ from C- on 10/9/2019 due to a significant decline in the total return index and volatility index.
Veracyte, Inc. (VCYT) was downgraded to D+ from C- on 10/9/2019 due to a significant decline in the total return index and volatility index.
C
Hold
7/31/2019Upgraded
Veracyte, Inc. (VCYT) was upgraded to C- from D+ on 7/31/2019 due to a noticeable increase in the total return index, solvency index and volatility index. The quick ratio increased from 5.89 to 13.86, and debt to equity declined from 0.32 to 0.01.
Veracyte, Inc. (VCYT) was upgraded to C- from D+ on 7/31/2019 due to a noticeable increase in the total return index, solvency index and volatility index. The quick ratio increased from 5.89 to 13.86, and debt to equity declined from 0.32 to 0.01.
D
Sell
2/26/2019Upgraded
Veracyte, Inc. (VCYT) was upgraded to D+ from D on 2/26/2019 due to a significant increase in the total return index, solvency index and growth index. Earnings per share increased from -$0.1157 to -$0.0762, operating cash flow increased 31.24% from -$1.78M to -$1.23M, and EBIT increased 28.97% from -$4.3M to -$3.06M.
Veracyte, Inc. (VCYT) was upgraded to D+ from D on 2/26/2019 due to a significant increase in the total return index, solvency index and growth index. Earnings per share increased from -$0.1157 to -$0.0762, operating cash flow increased 31.24% from -$1.78M to -$1.23M, and EBIT increased 28.97% from -$4.3M to -$3.06M.
D
Sell
10/30/2018Upgraded
Veracyte, Inc. (VCYT) was upgraded to D from D- on 10/30/2018 due to an increase in the total return index, efficiency index and growth index. Total capital increased 105.01% from $51.07M to $104.69M, operating cash flow increased 42.47% from -$3.1M to -$1.78M, and earnings per share increased from -$0.1821 to -$0.12.
Veracyte, Inc. (VCYT) was upgraded to D from D- on 10/30/2018 due to an increase in the total return index, efficiency index and growth index. Total capital increased 105.01% from $51.07M to $104.69M, operating cash flow increased 42.47% from -$3.1M to -$1.78M, and earnings per share increased from -$0.1821 to -$0.12.
D
Sell
12/28/2017Downgrade
Veracyte, Inc. (VCYT) was downgraded to D- from D on 12/28/2017 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.52 to 0.58, and the quick ratio declined from 5.32 to 4.71.
Veracyte, Inc. (VCYT) was downgraded to D- from D on 12/28/2017 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.52 to 0.58, and the quick ratio declined from 5.32 to 4.71.
D
Sell
7/20/2017Upgraded
Veracyte, Inc. (VCYT) was upgraded to D from D- on 7/20/2017 due to an increase in the volatility index.
Veracyte, Inc. (VCYT) was upgraded to D from D- on 7/20/2017 due to an increase in the volatility index.
D
Sell
7/5/2017Downgrade
Veracyte, Inc. (VCYT) was downgraded to D- from D on 7/5/2017 due to a decline in the total return index and volatility index.
Veracyte, Inc. (VCYT) was downgraded to D- from D on 7/5/2017 due to a decline in the total return index and volatility index.
D
Sell
5/26/2017Upgraded
Veracyte, Inc. (VCYT) was upgraded to D from D- on 5/26/2017 due to an increase in the volatility index.
Veracyte, Inc. (VCYT) was upgraded to D from D- on 5/26/2017 due to an increase in the volatility index.
D
Sell
5/11/2017Downgrade
Veracyte, Inc. (VCYT) was downgraded to D- from D on 5/11/2017 due to a large decline in the growth index, valuation index and efficiency index. EBIT declined 104.71% from -$3.67M to -$7.52M, operating cash flow declined 91.07% from -$4.23M to -$8.09M, and net income declined 86.62% from -$4.4M to -$8.22M.
Veracyte, Inc. (VCYT) was downgraded to D- from D on 5/11/2017 due to a large decline in the growth index, valuation index and efficiency index. EBIT declined 104.71% from -$3.67M to -$7.52M, operating cash flow declined 91.07% from -$4.23M to -$8.09M, and net income declined 86.62% from -$4.4M to -$8.22M.
D
Sell
3/3/2017Upgraded
Veracyte, Inc. (VCYT) was upgraded to D from D- on 3/3/2017 due to a substantial increase in the total return index, growth index and volatility index. Operating cash flow increased 43.1% from -$7.44M to -$4.23M, earnings per share increased from -$0.2019 to -$0.1389, and EBIT increased 24.85% from -$4.89M to -$3.67M.
Veracyte, Inc. (VCYT) was upgraded to D from D- on 3/3/2017 due to a substantial increase in the total return index, growth index and volatility index. Operating cash flow increased 43.1% from -$7.44M to -$4.23M, earnings per share increased from -$0.2019 to -$0.1389, and EBIT increased 24.85% from -$4.89M to -$3.67M.
D
Sell
3/11/2016Downgrade
Veracyte, Inc. (VCYT) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index and total return index.
Veracyte, Inc. (VCYT) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index and total return index.
D
Sell
8/14/2015Downgrade
Veracyte, Inc. (VCYT) was downgraded to D from D+ on 8/14/2015 due to a decline in the efficiency index, growth index and total return index.
Veracyte, Inc. (VCYT) was downgraded to D from D+ on 8/14/2015 due to a decline in the efficiency index, growth index and total return index.
D
Sell
6/19/2015Upgraded
Veracyte, Inc. (VCYT) was upgraded to D+ from D on 6/19/2015 due to an increase in the efficiency index, volatility index and growth index. Operating cash flow increased 5.11% from -$8.44M to -$8.87M.
Veracyte, Inc. (VCYT) was upgraded to D+ from D on 6/19/2015 due to an increase in the efficiency index, volatility index and growth index. Operating cash flow increased 5.11% from -$8.44M to -$8.87M.
D
Sell
5/14/2015Upgraded
Veracyte, Inc. (VCYT) was upgraded to D from D- on 5/14/2015 due to an increase in the total return index and valuation index.
Veracyte, Inc. (VCYT) was upgraded to D from D- on 5/14/2015 due to an increase in the total return index and valuation index.
D
Sell
4/27/2015Downgrade
Veracyte, Inc. (VCYT) was downgraded to D- from D on 4/27/2015 due to a major decline in the solvency index, valuation index and efficiency index. Debt to equity increased from 0.1 to 0.12, total capital declined 13.12% from $53.29M to $46.3M, and the quick ratio declined from 2.51 to 2.22.
Veracyte, Inc. (VCYT) was downgraded to D- from D on 4/27/2015 due to a major decline in the solvency index, valuation index and efficiency index. Debt to equity increased from 0.1 to 0.12, total capital declined 13.12% from $53.29M to $46.3M, and the quick ratio declined from 2.51 to 2.22.
D
Sell
11/3/2014Upgraded
Veracyte, Inc. (VCYT) was upgraded to D from D- on 11/3/2014 due to an increase in the valuation index.
Veracyte, Inc. (VCYT) was upgraded to D from D- on 11/3/2014 due to an increase in the valuation index.
D
Sell
7/1/2014Upgraded
Veracyte, Inc. (VCYT) was upgraded to D- from E+ on 7/1/2014 due to a significant increase in the efficiency index and solvency index. Net income increased 13.27% from -$5.89M to -$6.67M.
Veracyte, Inc. (VCYT) was upgraded to D- from E+ on 7/1/2014 due to a significant increase in the efficiency index and solvency index. Net income increased 13.27% from -$5.89M to -$6.67M.
E
Sell
4/1/2014Upgraded
Veracyte, Inc. (VCYT) was upgraded to E+ from E on 4/1/2014 due to a significant increase in the solvency index, total return index and growth index. The quick ratio increased from 1.29 to 4.7, debt to equity declined from -0.06 to 0.09, and total revenue increased 22.24% from $5.59M to $6.84M.
Veracyte, Inc. (VCYT) was upgraded to E+ from E on 4/1/2014 due to a significant increase in the solvency index, total return index and growth index. The quick ratio increased from 1.29 to 4.7, debt to equity declined from -0.06 to 0.09, and total revenue increased 22.24% from $5.59M to $6.84M.
NASDAQ
03/13/2025 4:00PM Eastern
Quotes delayed
